This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in ASM journals Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gumila, C. Articles by Vial, H. J. Search for Related Content PubMed PubMed Citation Articles by Gumila, C. Articles by Vial, H. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 03 1996, 602-608, Vol 40, No. 3
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Differential in vitro activities of ionophore compounds against Plasmodium falciparum and mammalian cells

C Gumila, ML Ancelin, G Jeminet, AM Delort, G Miquel and HJ Vial
Dynamique Moleculaire des Interactions Membranaires, Universite Montpellier II, France.

Twenty-two ionophore compounds were screened for their antimalarial activities. They consisted of true ionophores (mobile carriers) and channel-forming quasi-ionophores with different ionic specificities. Eleven of the compounds were found to be extremely efficient inhibitors of Plasmodium falciparum growth in vitro, with 50% inhibitory concentrations of less than 10 ng/ml. Gramicidin D was the most active compound tested, with 50% inhibitory concentration of 0.035 ng/ml. Compounds with identical ionic specificities generally had similar levels of antimalarial activity, and ionophores specific to monovalent cations were the most active. Compounds were further tested to determine their in vitro toxicities against mammalian lymphoblast and macrophage cell lines. Nine of the 22 compounds, i.e., alborixin, lonomycin, nigericin, narasin, monensin and its methylated derivative, lasalocid and its bromo derivative, and gramicidin D, most specific to monovalent cations, were at least 35-fold more active in vitro against P. falciparum than against the two other mammalian cell lines. The enhanced ability to penetrate the erythrocyte membrane after infection could be a factor that determines ionophore selectivity for infected erythrocytes.

This article has been cited by other articles:

• Radzishevsky, I., Krugliak, M., Ginsburg, H., Mor, A. (2007). Antiplasmodial Activity of Lauryl-Lysine Oligomers. Antimicrob. Agents Chemother. 51: 1753-1759 [Abstract] [Full Text]  
• Richier, E., Biagini, G. A., Wein, S., Boudou, F., Bray, P. G., Ward, S. A., Precigout, E., Calas, M., Dubremetz, J.-F., Vial, H. J. (2006). Potent Antihematozoan Activity of Novel Bisthiazolium Drug T16: Evidence for Inhibition of Phosphatidylcholine Metabolism in Erythrocytes Infected with Babesia and Plasmodium spp.. Antimicrob. Agents Chemother. 50: 3381-3388 [Abstract] [Full Text]  
• Ancelin, M. L., Calas, M., Vidal-Sailhan, V., Herbute, S., Ringwald, P., Vial, H. J. (2003). Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities. Antimicrob. Agents Chemother. 47: 2590-2597 [Abstract] [Full Text]  
• Butaye, P., Devriese, L. A., Haesebrouck, F. (2003). Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria. Clin. Microbiol. Rev. 16: 175-188 [Abstract] [Full Text]  
• Wengelnik, K., Vidal, V., Ancelin, M. L., Cathiard, A.-M., Morgat, J. L., Kocken, C. H., Calas, M., Herrera, S., Thomas, A. W., Vial, H. J. (2002). A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes. Science 295: 1311-1314 [Abstract] [Full Text]  
• Nagaraj, G., Uma, M. V., Shivayogi, M. S., Balaram, H. (2001). Antimalarial Activities of Peptide Antibiotics Isolated from Fungi. Antimicrob. Agents Chemother. 45: 145-149 [Abstract] [Full Text]